Dr Selina Tsim

  • Honorary Clinical Senior Lecturer (School of Cancer Sciences)

email: Selina.Tsim@glasgow.ac.uk

RI Cancer Sciences

Import to contacts

Publications

List by: Type | Date

Jump to: 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016
Number of items: 15.

2023

Ferguson, J. et al. (2023) Staging by Thoracoscopy in potentially radically treatable Lung Cancer associated with Minimal Pleural Effusion (STRATIFY): Protocol of a prospective, multicentre, observational study. BMJ Open Respiratory Research, 10, e001771. (doi: 10.1136/bmjresp-2023-001771) (PMID:37996118) (PMCID:PMC10668291)

Ferguson, K. et al. (2023) Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance. BMJ Open, 13, e067780. (doi: 10.1136/bmjopen-2022-067780) (PMID:37553196) (PMCID:PMC10414089)

2022

Kidd, A. C., Anderson, O., Cowell, G. W. , Weir, A. J., Voisey, J. P., Evison, M., Tsim, S., Goatman, K. A. and Blyth, K. G. (2022) Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria. Thorax, 77(12), pp. 1251-1259. (doi: 10.1136/thoraxjnl-2021-217808) (PMID:35110367)

2021

Tsim, S. et al. (2021) Serum proteomics and plasma fibulin-3 in differentiation of mesothelioma from asbestos-exposed controls and patients with other pleural diseases. Journal of Thoracic Oncology, 16(10), pp. 1705-1717. (doi: 10.1016/j.jtho.2021.05.018) (PMID:34116230) (PMCID:PMC8514249)

Taylor, S. et al. (2021) Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). BMJ Open Respiratory Research, 8(1), e000846. (doi: 10.1136/bmjresp-2020-000846) (PMID:34266853) (PMCID:PMC8286764)

2020

Tsim, S., Cowell, G. W. , Kidd, A., Woodward, R., Alexander, L., Kelly, C. , Foster, J. E. and Blyth, K. G. (2020) A comparison between MRI and CT in the assessment of primary tumour volume in mesothelioma. Lung Cancer, 150, pp. 12-20. (doi: 10.1016/j.lungcan.2020.09.025) (PMID:33039775)

Duffy, C. et al. (2020) Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter. BMJ Open, 7, e000710. (doi: 10.1136/bmjresp-2020-000710) (PMID:33148778) (PMCID:PMC7643431)

Ferguson, J. et al. (2020) Staging by Thoracoscopy in Potentially Radically Treatable Non-Small Cell Lung Cancer Associated with Minimal Pleural Effusion (STRATIFY) study: a prospective multicentre study. Lung Cancer, 139(1), S92. (doi: 10.1016/S0169-5002(20)30245-2)

2019

Tsim, S., Paterson, S., Cartwright, D., Fong, C. J., Alexander, L., Kelly, C. , Holme, J., Evison, M. and Blyth, K. G. (2019) Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups. Lung Cancer, 133, pp. 123-129. (doi: 10.1016/j.lungcan.2019.05.017) (PMID:31200818)

2018

Martin, G. A. , Tsim, S., Kidd, A. C., Foster, J. E., McLoone, P. , Chalmers, A. and Blyth, K. G. (2018) Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion. BMJ Open Respiratory Research, 5(1), e000293. (doi: 10.1136/bmjresp-2018-000293) (PMID:29862030) (PMCID:PMC5976095)

Tsim, S. et al. (2018) Early Contrast Enhancement: a novel Magnetic Resonance Imaging biomarker of pleural malignancy. Lung Cancer, 118, pp. 48-56. (doi: 10.1016/j.lungcan.2018.01.014) (PMID:29572002) (PMCID:PMC5884311)

Kidd, A. C., McGettrick, M., Tsim, S., Halligan, D. L., Bylesjo, M. and Blyth, K. G. (2018) Survival prediction in mesothelioma using a scalable lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respiratory Research, 5(1), e000240. (doi: 10.1136/bmjresp-2017-000240) (PMID:29468073) (PMCID:PMC5812388)

2017

Tsim, S., Stobo, D. B., Alexander, L., Kelly, C. and Blyth, K. G. (2017) The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy. Lung Cancer, 103, pp. 38-43. (doi: 10.1016/j.lungcan.2016.11.010) (PMID:28024694) (PMCID:PMC5226066)

2016

Tsim, S. et al. (2016) Diagnostic and prognostic biomarkers in the rational assessment of mesothelioma (DIAPHRAGM) study: protocol of a prospective, multi-centre, observational study. BMJ Open, 6(11), e013324. (doi: 10.1136/bmjopen-2016-013324) (PMID:27884852) (PMCID:PMC5168514)

Armato, S. G., Blyth, K. G. , Keating, J. J., Katz, S., Tsim, S., Coolen, J., Gudmundsson, E., Opitz, I. and Nowak, A. K. (2016) Imaging in pleural mesothelioma: a review of the 13th International Conference of the International Mesothelioma Interest Group. 2016 International Conference of the International Mesothelioma Interest Group (iMig), Birmingham, UK, 01-04 May 2016. pp. 48-58. (doi: 10.1016/j.lungcan.2016.09.003)

This list was generated on Sat Apr 20 06:11:48 2024 BST.
Number of items: 15.

Articles

Ferguson, J. et al. (2023) Staging by Thoracoscopy in potentially radically treatable Lung Cancer associated with Minimal Pleural Effusion (STRATIFY): Protocol of a prospective, multicentre, observational study. BMJ Open Respiratory Research, 10, e001771. (doi: 10.1136/bmjresp-2023-001771) (PMID:37996118) (PMCID:PMC10668291)

Ferguson, K. et al. (2023) Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance. BMJ Open, 13, e067780. (doi: 10.1136/bmjopen-2022-067780) (PMID:37553196) (PMCID:PMC10414089)

Kidd, A. C., Anderson, O., Cowell, G. W. , Weir, A. J., Voisey, J. P., Evison, M., Tsim, S., Goatman, K. A. and Blyth, K. G. (2022) Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria. Thorax, 77(12), pp. 1251-1259. (doi: 10.1136/thoraxjnl-2021-217808) (PMID:35110367)

Tsim, S. et al. (2021) Serum proteomics and plasma fibulin-3 in differentiation of mesothelioma from asbestos-exposed controls and patients with other pleural diseases. Journal of Thoracic Oncology, 16(10), pp. 1705-1717. (doi: 10.1016/j.jtho.2021.05.018) (PMID:34116230) (PMCID:PMC8514249)

Taylor, S. et al. (2021) Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). BMJ Open Respiratory Research, 8(1), e000846. (doi: 10.1136/bmjresp-2020-000846) (PMID:34266853) (PMCID:PMC8286764)

Tsim, S., Cowell, G. W. , Kidd, A., Woodward, R., Alexander, L., Kelly, C. , Foster, J. E. and Blyth, K. G. (2020) A comparison between MRI and CT in the assessment of primary tumour volume in mesothelioma. Lung Cancer, 150, pp. 12-20. (doi: 10.1016/j.lungcan.2020.09.025) (PMID:33039775)

Duffy, C. et al. (2020) Chest drain aerosol generation in COVID-19 and emission reduction using a simple anti-viral filter. BMJ Open, 7, e000710. (doi: 10.1136/bmjresp-2020-000710) (PMID:33148778) (PMCID:PMC7643431)

Ferguson, J. et al. (2020) Staging by Thoracoscopy in Potentially Radically Treatable Non-Small Cell Lung Cancer Associated with Minimal Pleural Effusion (STRATIFY) study: a prospective multicentre study. Lung Cancer, 139(1), S92. (doi: 10.1016/S0169-5002(20)30245-2)

Tsim, S., Paterson, S., Cartwright, D., Fong, C. J., Alexander, L., Kelly, C. , Holme, J., Evison, M. and Blyth, K. G. (2019) Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups. Lung Cancer, 133, pp. 123-129. (doi: 10.1016/j.lungcan.2019.05.017) (PMID:31200818)

Martin, G. A. , Tsim, S., Kidd, A. C., Foster, J. E., McLoone, P. , Chalmers, A. and Blyth, K. G. (2018) Pre-EDIT: protocol for a randomised feasibility trial of elastance-directed intrapleural catheter or talc pleurodesis (EDIT) in malignant pleural effusion. BMJ Open Respiratory Research, 5(1), e000293. (doi: 10.1136/bmjresp-2018-000293) (PMID:29862030) (PMCID:PMC5976095)

Tsim, S. et al. (2018) Early Contrast Enhancement: a novel Magnetic Resonance Imaging biomarker of pleural malignancy. Lung Cancer, 118, pp. 48-56. (doi: 10.1016/j.lungcan.2018.01.014) (PMID:29572002) (PMCID:PMC5884311)

Kidd, A. C., McGettrick, M., Tsim, S., Halligan, D. L., Bylesjo, M. and Blyth, K. G. (2018) Survival prediction in mesothelioma using a scalable lasso regression model: instructions for use and initial performance using clinical predictors. BMJ Open Respiratory Research, 5(1), e000240. (doi: 10.1136/bmjresp-2017-000240) (PMID:29468073) (PMCID:PMC5812388)

Tsim, S., Stobo, D. B., Alexander, L., Kelly, C. and Blyth, K. G. (2017) The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy. Lung Cancer, 103, pp. 38-43. (doi: 10.1016/j.lungcan.2016.11.010) (PMID:28024694) (PMCID:PMC5226066)

Tsim, S. et al. (2016) Diagnostic and prognostic biomarkers in the rational assessment of mesothelioma (DIAPHRAGM) study: protocol of a prospective, multi-centre, observational study. BMJ Open, 6(11), e013324. (doi: 10.1136/bmjopen-2016-013324) (PMID:27884852) (PMCID:PMC5168514)

Conference or Workshop Item

Armato, S. G., Blyth, K. G. , Keating, J. J., Katz, S., Tsim, S., Coolen, J., Gudmundsson, E., Opitz, I. and Nowak, A. K. (2016) Imaging in pleural mesothelioma: a review of the 13th International Conference of the International Mesothelioma Interest Group. 2016 International Conference of the International Mesothelioma Interest Group (iMig), Birmingham, UK, 01-04 May 2016. pp. 48-58. (doi: 10.1016/j.lungcan.2016.09.003)

This list was generated on Sat Apr 20 06:11:48 2024 BST.